Paradigm Clinical Research Expands Into Boise, Idaho, Advancing the Company’s Portfolio of Therapeutic Area Expertise

Paradigm Clinical Research, a leading clinical research site business, announces the opening of its latest clinical research site in Boise, Idaho.

This marks a significant milestone as the company establishes its first site in Idaho, further advancing its footprint and its portfolio of therapeutic areas including women’s health studies. This emphasizes Paradigm Clinical Research’s commitment to making meaningful differences in the lives of the individuals and communities the company serves.

The Boise site complements the company’s existing locations, reinforcing Paradigm Clinical Research’s dedication to establishing purpose-built research sites that cater to the growing demand for study participants and the crucial need for diverse populations and investigators. The expansion in Boise includes the company’s growing roster of partner investigators, including Dr. Keri Erland, Dr. Kelly Siudzinski, Dr. Tara Erbele, and Dr. Roger Wyatt, all playing pivotal roles in bringing clinical trial opportunities to the greater Treasure Valley community.

Kurt Mussina, CEO of Paradigm Clinical Research, emphasized the unique aspect of this expansion, stating, “Boise represents more than a geographic extension for us; it’s an opportunity to make further strides in women's health and our other therapeutic areas of interest. We are not merely opening a new location; we are expanding our commitment to advancing healthcare, particularly in areas that matter most to the community."